The significant fall in antibiotic use in food-producing animals suggests that the measures taken at country level to reduce use are proving to be effective, these are the conclusions of a recent report published from the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Agency (EFSA). In particular, the use […]

On July 13, the Committee on the Environment, Public Health and Food Safety (ENVI) adopted, with 67 votes in favour, 10 against and one abstention, a draft negotiating position for a new regulation on tackling serious cross-border health threats. The text will be voted by all MEPs during September’s plenary session. Enhanced cooperation and transparency […]

On July 12 and 13, the Commission is hosting a new pan-European matchmaking event to accelerate and upscale the development and production of COVID-19 therapeutics in the EU. With the spread of variants and the resurgence of cases across the EU in recent weeks, the development of therapeutics is more necessary than ever, the Commission […]

On 8 July the Court of Justice of the European Union (CJEU) issued its judgement in Case C-178/20, concerning the placement on the market of medicinal products not subject to medical prescription in one Member State where a marketing authorisation (MA) has been granted by competent authorities. Recalling the Directive 2001/83/EC of the European Parliament […]

Early on June 22, the European Parliament and the Council negotiators reached a provisional agreement on the increased cooperation of member states on health technology assessment (HTA) at EU level. After years of ongoing discussions, the co-legislators struck a political deal on a legislative proposal concerning joint work on HTA. “We have reached a decisive […]

The Council adopted yesterday position on the Commission proposal to give the European Medicines Agency (EMA) a stronger role in crisis preparedness and management. “The European Medicines Agency has been an essential partner in our response to the COVID-19 pandemic. But the crisis has shown that we cannot take for granted the availability of medicines […]

Since 2017, the European Union of General Practitioners (UEMO) has participated as “health provider” in the Health Technologies Assessment (HTA) stakeholder pool of the European Commission [1, 2] and in the EUnetHTA annual forum [3]. The project, the European Regulation on HTA, is currently going through the process of trilogue, a meeting between the European […]

On May 18, UEMO attended a workshop organized by the European Medicines Agency (EMA) on data strategy. The medicines agency launched an initiative to develop a data standards strategy, with a view to addressing the HMA/EMA Big Data Task Force recommendation to engage in international initiatives related to data standardisation. The strategy will enable the […]

On May 11, UEMO was featured in the Spanish medical publication “Médicos y Pacientes”, the official communication medium of the Spanish General Medical Council (CGCOM). The publication was a special feature in light of the celebration of European Doctors’ Day (May 15). “During the COVID-19 pandemic, UEMO has been committed to supporting general practitioners / […]